PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26511508-7 2015 Using in silico modeling and drug-target interaction studies, we identified that the U.S. Food and Drug Administration-approved thrombin inhibitor argatroban is a Morf4l1 antagonist. argatroban 147-157 mortality factor 4 like 1 Mus musculus 163-170 26511508-8 2015 Argatroban inhibited Morf4l1-dependent histone acetylation, reduced its cytotoxicity, and improved survival of mice with experimental lung injury at doses that had no anticoagulant activity. argatroban 0-10 mortality factor 4 like 1 Mus musculus 21-28 32694659-6 2020 Blocking of MRG15 by CRISPR targeting or by the FDA-approved drug argatroban, which is an antagonist to MRG15, attenuates liver steatosis. argatroban 66-76 mortality factor 4 like 1 Mus musculus 12-17 32694659-6 2020 Blocking of MRG15 by CRISPR targeting or by the FDA-approved drug argatroban, which is an antagonist to MRG15, attenuates liver steatosis. argatroban 66-76 mortality factor 4 like 1 Mus musculus 104-109